当有了卵胞浆内单精子注射,谁还关注少精症
本文指出,不加区分地对少精症男性提供卵胞浆内单精子注射(ICSI)并非没有潜在不良影响,也不能为不育男性提供最佳生育路径。近期数据支持少精症与男性生殖健康不良、精子DNA和表观遗传损伤及后代可能的不良健康后果相关。多种影响睾丸的疾病可导致少精症。若发现少精症,治疗干预可改善精子数量/质量和男性整体健康,即使使用ICSI也能获得更好的妊娠结局。敦促生育诊所让男性不育专家参与少精症的诊断和治疗。
要点
- 不加区分地对少精症男性提供ICSI并非没有潜在不良影响。
- 少精症与男性生殖健康不良、精子DNA和表观遗传损伤相关。
- 发现少精症时,治疗干预可改善精子数量/质量和男性整体健康。
核心结论
- 不加区分地对少精症男性提供ICSI并非没有潜在不良影响,也不能为不育男性提供最佳生育路径。
- 敦促生育诊所让男性不育专家参与少精症的诊断和治疗,作为最佳临床实践。
- 若发现少精症,治疗干预可改善精子数量/质量和男性整体健康,最终即使使用ICSI也能获得更好的妊娠结局。
研究设计与样本
- 本文为论述性文章,未报告系统检索范围或样本量。
主要发现
- 近期数据支持少精症与男性生殖健康不良、精子DNA和表观遗传损伤及后代可能的不良健康后果之间的关联。
- 多种影响睾丸的疾病可导致少精症,包括精索静脉曲张、生殖道感染、先天性和遗传缺陷、睾丸扭转/创伤、慢性疾病、不良生活方式、职业/环境有毒物暴露、药物、癌症及相关治疗、急性发热性疾病、内分泌疾病和泌尿生殖系统医源性损伤。
- 良好的男性不育评估是识别相关医学和不育状况的独特机会,许多状况可能被治疗或缓解。
- 男科评估也可能有助于指导ICSI的最佳应用。
临床怎么用
- 敦促生育诊所让男性不育专家参与少精症的诊断和治疗,作为最佳临床实践。
- 最终目标是积极影响患者整体健康、夫妇妊娠前景和后代的健康。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The value of assessing subfertile males with oligozoospermia is controversial due to prevailing notions that therapies are limited and ICSI may provide the couple with a baby without the need to explain the nature or cause of underlying male infertility. This article highlights that indiscriminately offering ICSI to oligozoospermic men is not free of potential adverse effects and does not grant subfertile men the best fertility pathway. Recent data support associations between oligozoospermia and poor male reproductive health, DNA and epigenetic damage in spermatozoa, and possible adverse health consequences to offspring. Many conditions affecting the testicles are capable of causing oligozoospermia (varicocele, genital infections, congenital and genetic defects testicular torsion/trauma, chronic diseases, inadequate lifestyle, occupational/environmental exposure to toxicants, drugs, cancer and related treatments, acute febrile illness, endocrine disorders, and iatrogenic damage to the genitourinary system). If oligozoospermia is detected, therapeutic interventions can improve sperm quantity/quality and the overall male health, ultimately resulting in better pregnancy outcomes even when ICSI is used. Fertility clinics are urged to engage male infertility specialists in diagnosing and treating oligozoospermia as a matter of best clinical practice. A well-conducted male infertility evaluation represents a unique opportunity to identify relevant medical and infertility conditions, many of which may be treated or alleviated. The andrological assessment may also help guide the optimal application of ICSI. The final goals are to positively impact the overall patient health, the couple's pregnancy prospects, and the offspring's well-being.
引用
- Esteves SC. Who cares about oligozoospermia when we have ICSI. Reprod Biomed Online. 2021. PMID: 35153142. doi:10.1016/j.rbmo.2021.11.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。